Genome Engineering in Accelerating Discovery and Preclinical Applications

Genome Engineering in Accelerating Discovery and Preclinical Applications

Speaker: Dan (Xiaodan) Wang, Ph.D. Associate Director of Gene Targeting

  • When CRISPR/Cas9 technology is applied to generate Genetically Modified Models, common challenges include transgene silencing, karyotype abnormalities, off-targeting risks, random integrations and mosaicism.
  • To minimize the off-targeting effect and enhance the specificity, we design sgRNAs by combining the results from CCTop, Sanger and CrispRGold; The sgRNA is chosen based on UCA assay and other factors.
  • Use of our CRISPR-based Extreme Genome Editing technology improves the efficiency of large fragment knock-in by up to 10-20 fold, meaning we can generate targeted cell lines, mouse and rat models in industry-leading timelines with a 98% success rate.

Share:

Please fill out the form below to request a download of this Webinar









You have successfully subscribed to the newsletter!

There was an error while trying to send your request. Please try again.

Biocytogen will use the information you provide on this form to be in touch with you and to provide updates and marketing.